Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
322,631
-
Shares change
-
+23,930
-
Total reported value, excl. options
-
$1,423,182
-
Value change
-
+$122,726
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$4.41
Significant Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q2 2023
14 filings reported holding BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value as of Q2 2023.
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 322,631 shares
of 8,896,104 outstanding shares and own 3.63% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (126,956 shares), Wealth Alliance (44,316 shares), GEODE CAPITAL MANAGEMENT, LLC (43,776 shares), Mariner, LLC (26,668 shares), TWO SIGMA ADVISERS, LP (26,300 shares), STATE STREET CORP (20,459 shares), StoneX Group Inc. (14,886 shares), WELLS FARGO & COMPANY/MN (11,562 shares), UBS Group AG (3,079 shares), and Steward Partners Investment Advisory, LLC (2,000 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.